A detailed history of Freestone Capital Holdings, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 19,143 shares of DXCM stock, worth $1.54 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
19,143
Previous 15,119 26.62%
Holding current value
$1.54 Million
Previous $1.71 Million 25.2%
% of portfolio
0.04%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $257,536 - $467,025
4,024 Added 26.62%
19,143 $1.28 Million
Q2 2024

Nov 22, 2024

BUY
$110.31 - $140.45 $97,514 - $124,157
884 Added 6.21%
15,119 $1.71 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $97,514 - $124,157
884 Added 6.21%
15,119 $1.71 Million
Q1 2024

Nov 22, 2024

SELL
$114.22 - $140.1 $560,591 - $687,610
-4,908 Reduced 25.64%
14,235 $1.97 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $71,958 - $88,263
630 Added 4.63%
14,235 $1.97 Million
Q4 2023

Feb 13, 2024

BUY
$75.49 - $124.16 $32,989 - $54,257
437 Added 3.32%
13,605 $1.69 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $256,889 - $411,721
2,985 Added 29.31%
13,168 $1.23 Million
Q2 2023

Aug 09, 2023

BUY
$112.47 - $130.98 $13,158 - $15,324
117 Added 1.16%
10,183 $1.31 Million
Q1 2023

May 12, 2023

SELL
$104.0 - $122.92 $10,400 - $12,292
-100 Reduced 0.98%
10,066 $1.17 Million
Q4 2022

Feb 13, 2023

SELL
$84.98 - $122.67 $16,571 - $23,920
-195 Reduced 1.88%
10,166 $1.15 Million
Q3 2022

Nov 09, 2022

SELL
$76.35 - $94.18 $47,260 - $58,297
-619 Reduced 5.64%
10,361 $834,000
Q2 2022

Aug 09, 2022

BUY
$67.99 - $132.89 $538,888 - $1.05 Million
7,926 Added 259.53%
10,980 $818,000
Q1 2022

May 12, 2022

BUY
$94.08 - $130.2 $125,596 - $173,816
1,335 Added 77.66%
3,054 $1.56 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $38,571 - $48,357
297 Added 20.89%
1,719 $923,000
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $151,741 - $203,601
1,422 New
1,422 $778,000
Q1 2021

May 17, 2021

SELL
$84.79 - $104.74 $9,750 - $12,045
-115 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $4,368 - $5,852
56 Added 94.92%
115 $42.5 Million
Q3 2020

Nov 06, 2020

BUY
$95.51 - $112.95 $5,635 - $6,664
59 New
59 $6,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.